Charles River Laboratories International (CRL) Other Non-Current Liabilities (2009 - 2026)

Charles River Laboratories International has reported Other Non-Current Liabilities for 18 years, with the latest figure at $402.5 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 117.33% year-over-year to $402.5 million in Q2 2026; TTM through Jun 2026 was $402.5 million, a 117.33% increase from a year earlier, with the FY2025 full-year figure at $138.3 million, down 29.15% from the prior year.
• Other Non-Current Liabilities was $402.5 million for Q2 2026 at Charles River Laboratories International, down from $510.6 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $510.6 million in Q1 2026, with the low at $138.3 million in Q4 2025.
• Average Other Non-Current Liabilities over 5 years is $226.6 million, with a median of $195.1 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Liabilities decreased 29.15% in 2025, then soared 160.01% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $174.8 million in 2022, then increased by 27.67% to $223.2 million in 2023, then fell by 12.54% to $195.2 million in 2024, then dropped by 29.15% to $138.3 million in 2025, then jumped by 191.04% to $402.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $402.5 million (Q2 2026), $510.6 million (Q1 2026), and $138.3 million (Q4 2025), per Business Quant data.